Stakeholders now have until Oct. 6 to share their thoughts on the proposed FDA rule. Read More
The commentary highlights findings of a recent survey about misperceptions of harms.Read More
The new platform describes an array of advisory services to nicotine and cannabis clients, Read More
The dispute centers on whether certain cigarettes were sold before or after a 2015 tax hike.Read More
The industry veteran will help develop and execute business development strategies.Read More
New York City says the defendants illegally sold flavored vaping products.Read More
The company did not demonstrate that the product’s benefit outweighs the risks. Read More
The ban also includes the advertising of vaping products in Ukraine.Read More
ENDS may still be registered as a prescription-only medicine for smoking cessation.Read More
Tobacco Control Act allows FDA to require manufacturers submit comparative health risk data.Read More
